Literature DB >> 20494478

Hansen's disease (leprosy) complicated by secondary mycobacterial infection.

David M Scollard1, Barbara M Stryjewska, John F Prestigiacomo, Thomas P Gillis, Jennifer Waguespack-Labiche.   

Abstract

A patient with Hansen's disease received corticosteroids for a type 1 leprosy reaction and subsequently developed a new cutaneous lesion at the original biopsy site from which Mycobacterium fortuitum was cultured. A review of the literature found only two other cases of coinfection with atypical mycobacteria and Mycobacterium leprae, although there are many reports of pulmonary tuberculosis in patients with leprosy. This case highlights the diagnostic difficulties encountered when a patient has two different mycobacterial infections of the skin. The published experience emphasizes that such coinfection is remarkably uncommon in leprosy, despite the frequent use of high doses of corticosteroids for leprosy reactions.
Copyright © 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20494478     DOI: 10.1016/j.jaad.2009.10.004

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.

Authors:  Maria Ângela B Trindade; Denise Miyamoto; Gil Benard; Neusa Y Sakai-Valente; Dewton de M Vasconcelos; Bernard Naafs
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

2.  Mycobacterium leprae transmission characteristics during the declining stages of leprosy incidence: A systematic review.

Authors:  Thomas Hambridge; Shri Lak Nanjan Chandran; Annemieke Geluk; Paul Saunderson; Jan Hendrik Richardus
Journal:  PLoS Negl Trop Dis       Date:  2021-05-26

3.  Leprosy and hepatitis B coinfection in southern Brazil.

Authors:  Cleverson Leitão; Denis Ueda; Anna Carolina de Moraes Braga; Angelica B W Boldt; Iara J T Messias-Reason
Journal:  Braz J Infect Dis       Date:  2013-08-06       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.